Differences in Non-Hodgkin Lymphoma (NHL) patients with and without femur fracture in patients age < 65 versus > 65 years - results from a cross-sectional study

被引：0
|
作者：
Reske, T. [1 ]
Cefalu, C. [1 ]
Loch, M. [2 ]
机构：
[1] LSU HSC New Orleans, Geriatr Sect, New Orleans, LA USA
[2] LSU HSC New Orleans, Dept Med, New Orleans, LA USA
来源：
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY | 2014年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页码：S45 / S45
页数：1
相关论文
共 50 条
  • [41] Intensive chemotherapy with hematopoietic cell transplantation after ESHAP therapy for relapsed or refractory non-Hodgkin's lymphoma.: Results of a single-centre study of 65 patients
    Soussain, C
    Souleau, B
    Gabarre, J
    Zouabi, H
    Sutton, L
    Boccaccio, C
    Albin, N
    Charlotte, F
    Merle-Béral, H
    Delort, J
    Binet, JL
    Leblond, V
    LEUKEMIA & LYMPHOMA, 1999, 33 (5-6) : 543 - 550
  • [42] Similar Efficacy and Safety of Basaglar® and Lantus® in Patients with Type 2 Diabetes in Age Groups (< 65 Years, ≥ 65 Years): A Post Hoc Analysis from the ELEMENT-2 Study
    Pollom, Robyn K.
    Costigan, Timothy
    Lacaya, Lyndon B.
    Ilag, Liza L.
    Hollander, Priscilla A.
    DIABETES THERAPY, 2018, 9 (02) : 827 - 837
  • [43] Results of a multi-center, phase II study of Elsamitrucin (SPI-28090) in patients with relapsed or refractory non-Hodgkin's lymphoma (NHL).
    Foon, K
    Allen, S
    Sen, K
    Mohrbacher, A
    Sanani, S
    Lenaz, L
    Rosales, R
    BLOOD, 2005, 106 (11) : 265B - 266B
  • [44] Stereotactic radiosurgery for brain metastases: a case-matched study comparing treatment results for patients 80 years of age or older versus patients 65-79 years of age
    Watanabe, Shinya
    Yamamoto, Masaaki
    Sato, Yasunori
    Kawabe, Takuya
    Higuchi, Yoshinori
    Kasuya, Hidetoshi
    Yamamoto, Tetsuya
    Matsumura, Akira
    Barfod, Bierta E.
    JOURNAL OF NEUROSURGERY, 2014, 121 (05) : 1148 - 1157
  • [45] ASSOCIATION BETWEEN COGNITIVE DYSFUNCTION AND DIABETES IN PATIENTS OVER 65 YEARS OLD: A CROSS-SECTIONAL STUDY USING PROPENSITY SCORE MATCHING
    Zhai, Liwen
    Yang, Yao
    Zhang, Jun
    Hou, Weiqian
    Yang, Yujie
    Ding, Dongfang
    Li, Conghui
    Zhu, Yi
    JOURNAL OF REHABILITATION MEDICINE, 2024, 56
  • [46] Glofitamab monotherapy retreatment in patients with heavily pre-treated relapsed or refractory (R/R) non-Hodgkin lymphoma (NHL): Results from a phase I/II study
    Bartlett, Nancy L.
    Dickinson, Michael
    Hutchings, Martin
    Carlo-Stella, Carmelo
    Wu, Shang-Ju
    Leppa, Sirpa
    Trneny, Marek
    Corradini, Paolo
    Offner, Fritz
    Mulvihill, Estefania
    Bottos, Alessia
    Chohan, Saibah
    Baumlin, Pauline
    Relf, James
    Lundberg, Linda
    Bachy, Emmanuel
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [47] PRELIMINARY RESULTS OF A PHASE II RANDOMIZED STUDY (ROMULUS) OF POLATUZUMAB VEDOTIN OR PINATUZUMAB VEDOTIN PLUS RITUXIMAB IN PATIENTS WITH RELAPSED/REFRACTORY NON-HODGKIN LYMPHOMA (NHL)
    Morschhauser, F.
    Flinn, I.
    Advani, R.
    Sehn, L.
    Kolibaba, K.
    Press, O.
    Salles, G.
    Diefenbach, C.
    Tilly, H.
    Assouline, S.
    Chen, A.
    Dreyling, M.
    Hagenbeek, A.
    Zinzani, P. L.
    Cheson, B. D.
    Yalamanchili, S.
    Lu, D.
    Chai, A.
    Chu, Y. W.
    Sharman, J.
    HAEMATOLOGICA, 2014, 99 : 525 - 525
  • [48] ANEMIA AND DARBEPOETIN ALFA ADMINISTRATION IN PATIENTS TREATED WITH CHOP+/-R CHEMOTHERAPY: RESULTS FROM AN OBSERVATIONAL STUDY OF PATIENTS WITH NON-HODGKIN LYMPHOMA
    Haioun, C.
    Lugtenburg, P.
    Pettengell, R.
    Johnsen, H. E.
    Duehrsen, U.
    Rossi, F. G.
    Verhoef, G.
    Schwenkglenks, M.
    Pujol, B.
    Salar, A.
    ANNALS OF ONCOLOGY, 2010, 21 : 387 - 387
  • [49] Preliminary Results of a Phase II Randomized Study (ROMULUS) of Polatuzumab Vedotin or Pinatuzumab Vedotin Plus Rituximab in Patients With Relapsed/Refractory Non-Hodgkin Lymphoma (NHL)
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2014, 12 (08) : 15 - 18
  • [50] Phase II study of sphingosomal vincristine in CHOP± rituximab for patients with aggressive non-Hodgkin's lymphoma (NHL):: Promising 3 year follow-up results in elderly patients
    Rodriguez, MA
    Dung, NH
    Fayad, L
    Goy, A
    Hagemeister, F
    McLaughlin, P
    Pro, B
    Romaguera, J
    Younes, A
    Cabanillas, F
    BLOOD, 2005, 106 (11) : 277A - 277A
12345